Data / Form D filings / IGY Immune Technologies & Life Sciences Inc.
IGY Immune Technologies & Life Sciences Inc.: Form D filings
IGY Immune Technologies & Life Sciences Inc., a biotechnology company in Thunder Bay, Ontario, Canada, filed 2 Form D notices with the SEC between 2011 and 2012. The latest, on February 22, 2012, reports $65,100 sold of a $1 million offering to 2 investors.
Find out what IGY Immune Technologies & Life Sciences Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 40 S CUMBERLAND STREET, Thunder Bay, Ontario, Canada, P7B 2
- Phone
- (807) 343-6013
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Year incorporated
- 2009
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1482985
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 22, 2012 | Amendment | $1,000,000 | $65,100 | $934,900 | 2 | Sep 19, 2011 | sec.gov |
| Sep 23, 2011 | New notice | $30,000 | $30,000 | $0 | 2 | Sep 19, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Terry Dyck | Executive Officer, Director | |
| Sharad Mistry | Executive Officer, Director |
Every Form D from the week of Feb 20, 2012 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what IGY Immune Technologies & Life Sciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.